Effect of Unani Formulation in Kidney stone.
Phase 2
- Conditions
- Health Condition 1: N202- Calculus of kidney with calculus of ureter
- Registration Number
- CTRI/2020/04/024420
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Diagnosed case of Hasat-e-Bauliyah (Urolithiasis) up to 10 mm (radiological evidence of stone up to 10mm
2.Patients who have agreed to sign the informed consent form and follow up the protocol.
Exclusion Criteria
1.Stone size more than 10 mm.
2.K/C/O Diabetes mellitus.
3.Pregnant and lactating women.
4.Gross hydronephrosis
5.Raised blood urea or serum creatinine
6.Bladder outlet obstruction
•Serious systemic illness
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in the objective parameters <br/ ><br>Urine (Routine & Microscopic) <br/ ><br>USG abdomen and pelvis (esp. KUB) <br/ ><br>Blood urea and Serum creatinine <br/ ><br>Timepoint: 0th day, 15th day, 30th day, 45th day. <br/ ><br>
- Secondary Outcome Measures
Name Time Method Improvement in the subjective parameters. <br/ ><br>Pain in abdomen <br/ ><br>Burning micturition <br/ ><br>Hematuria <br/ ><br>Nausea <br/ ><br>Vomiting <br/ ><br>Timepoint: 0th day, 15th day, 30th day, 45th day.